GPT-5.4-Cyber (OpenAI) vs GPT-Rosalind (OpenAI)
Which one should you pick? Here's the full breakdown.
GPT-5.4-Cyber (OpenAI)
OpenAI's defensive-cybersecurity variant of GPT-5.4, launched 2026-04-16. Lowered refusal boundary for security-research tasks and native binary reverse-engineering. Access gated via Trusted Access for Cyber (TAC) program -- thousands of verified defenders, hundreds of teams, no public pricing
GPT-Rosalind (OpenAI)
OpenAI's first domain-specific model -- life sciences, drug discovery, translational medicine. Launched 2026-04-16 as a Trusted Access research preview. Launch partners: Amgen, Moderna, Allen Institute, Thermo Fisher. Paired with a Life Sciences Codex plugin (50+ scientific tool integrations)
| Category | GPT-5.4-Cyber (OpenAI) | GPT-Rosalind (OpenAI) |
|---|---|---|
| Ease of Use | 5.0 | 3.0 |
| Output Quality | 8.5 | 9.0 |
| Value | 7.0 | 7.0 |
| Features | 8.0 | 8.0 |
| Overall | 7.2 | 6.8 |
Pricing Comparison
| Feature | GPT-5.4-Cyber (OpenAI) | GPT-Rosalind (OpenAI) |
|---|---|---|
| Free Tier | No | No |
| Starting Price | Not publicly disclosed | Invite only |
Which Should You Pick?
Pick GPT-5.4-Cyber (OpenAI) if...
- ✓Easier to use (5 vs 3)
Enterprise SOC teams, established security research orgs, and vetted individual defenders who can qualify for Trusted Access for Cyber. Strongest fit if your work involves binary analysis, vulnerability research, or defensive-security tooling where standard GPT-5.4 refusals actually block the work.
Visit GPT-5.4-Cyber (OpenAI)Pick GPT-Rosalind (OpenAI) if...
Researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get Trusted Access. Also relevant to anyone building life-sciences AI products who needs to understand where OpenAI's vertical strategy is heading.
Visit GPT-Rosalind (OpenAI)Our Verdict
GPT-5.4-Cyber (OpenAI) edges out GPT-Rosalind (OpenAI) with a 7.2 vs 6.8 overall score. Both are solid picks, but GPT-5.4-Cyber (OpenAI) has the advantage in features.